JP2009538935A5 - - Google Patents

Download PDF

Info

Publication number
JP2009538935A5
JP2009538935A5 JP2009513472A JP2009513472A JP2009538935A5 JP 2009538935 A5 JP2009538935 A5 JP 2009538935A5 JP 2009513472 A JP2009513472 A JP 2009513472A JP 2009513472 A JP2009513472 A JP 2009513472A JP 2009538935 A5 JP2009538935 A5 JP 2009538935A5
Authority
JP
Japan
Prior art keywords
myxoma virus
activity
group
cancer
myxoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009513472A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009538935A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/070219 external-priority patent/WO2007143548A2/en
Publication of JP2009538935A publication Critical patent/JP2009538935A/ja
Publication of JP2009538935A5 publication Critical patent/JP2009538935A5/ja
Withdrawn legal-status Critical Current

Links

JP2009513472A 2006-06-01 2007-06-01 癌の処置のための粘液腫ウイルス変異体 Withdrawn JP2009538935A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80364006P 2006-06-01 2006-06-01
PCT/US2007/070219 WO2007143548A2 (en) 2006-06-01 2007-06-01 Myxoma virus mutants for cancer treatment

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013040387A Division JP5665899B2 (ja) 2006-06-01 2013-03-01 癌の処置のための粘液腫ウイルス変異体

Publications (2)

Publication Number Publication Date
JP2009538935A JP2009538935A (ja) 2009-11-12
JP2009538935A5 true JP2009538935A5 (https=) 2010-07-08

Family

ID=38802246

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2009513472A Withdrawn JP2009538935A (ja) 2006-06-01 2007-06-01 癌の処置のための粘液腫ウイルス変異体
JP2013040387A Expired - Fee Related JP5665899B2 (ja) 2006-06-01 2013-03-01 癌の処置のための粘液腫ウイルス変異体
JP2014248831A Pending JP2015044878A (ja) 2006-06-01 2014-12-09 癌の処置のための粘液腫ウイルス変異体
JP2016197808A Pending JP2017008105A (ja) 2006-06-01 2016-10-06 癌の処置のための粘液腫ウイルス変異体

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2013040387A Expired - Fee Related JP5665899B2 (ja) 2006-06-01 2013-03-01 癌の処置のための粘液腫ウイルス変異体
JP2014248831A Pending JP2015044878A (ja) 2006-06-01 2014-12-09 癌の処置のための粘液腫ウイルス変異体
JP2016197808A Pending JP2017008105A (ja) 2006-06-01 2016-10-06 癌の処置のための粘液腫ウイルス変異体

Country Status (12)

Country Link
US (3) US8512713B2 (https=)
EP (3) EP2457584B1 (https=)
JP (4) JP2009538935A (https=)
KR (1) KR20090014364A (https=)
CN (1) CN101460194B (https=)
AU (1) AU2007256754B2 (https=)
CA (2) CA2652228C (https=)
IL (1) IL195297A (https=)
MX (1) MX2008015265A (https=)
NZ (1) NZ572893A (https=)
WO (1) WO2007143548A2 (https=)
ZA (1) ZA200809769B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007143548A2 (en) 2006-06-01 2007-12-13 Robarts Research Institute Myxoma virus mutants for cancer treatment
FR2946536B1 (fr) * 2009-06-11 2011-07-29 Agronomique Inst Nat Rech Utilisation d'une souche attenuee de myxoma virus comme oncolytique
US12128099B2 (en) 2018-05-25 2024-10-29 Bioventures, Llc Myxoma virus compositions and methods of use
CA3112788A1 (en) * 2018-09-05 2020-03-12 Arizona Board Of Regents On Behalf Of Arizona State University Oncolytic virus platform to treat hematological cancer
US12428626B2 (en) 2018-11-20 2025-09-30 Bioventures, Llc Cells for the production of viruses and methods of using the same

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101618049A (zh) 1997-10-09 2010-01-06 威尔斯塔特生物公司 使用病毒来治疗赘生物
ES2153284B1 (es) 1998-06-10 2001-09-01 Fundacion Para El Estudio Y De Nuevo virus recombinante de mixoma atenuado y su uso en la preparacion de vacunas mixtas contra la mixomatosis y la enfermedad hemorragica de los conejos.
IL145899A0 (en) 1999-04-15 2002-07-25 Pro Virus Inc Treatment of neoplasms with viruses
AU6175000A (en) 1999-07-12 2001-01-30 Viron Therapeutics, Inc. Novel myxoma genes for immune modulation
WO2001087324A1 (en) 2000-05-17 2001-11-22 Viron Therapeutics, Inc. Compositions and methods for promoting immunosuppression
BR0207761A (pt) * 2001-03-08 2006-01-31 Akzo Nobel Nv Uso de um vìrus leporipox recombinante vivo, vacina, e, vìrus leporipox recombinante vivo
JP4800924B2 (ja) * 2003-03-07 2011-10-26 ロバーツ リサーチ インスティテュート 癌および慢性ウイルス感染の治療処置のための粘液腫症ウイルスの使用
US20070207149A1 (en) 2004-04-27 2007-09-06 Wellstat Biologics Corporation Cancer treatment using viruses and camptothecins
US20090035276A1 (en) 2005-03-07 2009-02-05 Robarts Research Institute Use of a combination of myxoma virus and rapamycin for therapeutic treatment
WO2007143545A2 (en) 2006-06-01 2007-12-13 Robarts Research Institute Tnf signaling in myxoma virus treatments
WO2007143548A2 (en) 2006-06-01 2007-12-13 Robarts Research Institute Myxoma virus mutants for cancer treatment
WO2007147118A1 (en) 2006-06-16 2007-12-21 Robarts Research Institute Infection of cells with myxoma virus requires akt activation

Similar Documents

Publication Publication Date Title
JP7851633B2 (ja) アンモニア酸化Nitrosomonas eutropha株D23
He et al. Oxidative stress, inflammation, and autophagy: potential targets of mesenchymal stem cells-based therapies in ischemic stroke
Geng et al. Biomimetic nanovehicle-enabled targeted depletion of intratumoral Fusobacterium nucleatum synergizes with PD-L1 blockade against breast cancer
TR201903587T4 (tr) Telomeraz aktivitesinin artırılması için bileşimler.
JP6505681B2 (ja) Flt3変異を有する急性骨髄性白血病を治療するための医薬組成物
JP2008519047A5 (https=)
EP1385466A4 (en) ONCOLYTIC VIRUS THERAPY
CN112007163B (zh) 用于治疗非洲猪瘟的药物组合物及其用途
CN104884055A (zh) 柠檬酸铁在治疗慢性肾脏疾病患者中的应用
JP2011225596A5 (https=)
JP2016539156A5 (https=)
BRPI0411098A (pt) benzofuranocarboxamidas, com atividade pi3k, como agentes terapêuticos
BR112013005673A2 (pt) uso de lipase de ácido lisossomal para tratamento de deficiência de lipase de ácido lisossomal em pacientes
EA200800663A1 (ru) Способ и средство профилактики и лечения нарушенного дыхания во время сна
JP2018509388A5 (https=)
JP2009538935A5 (https=)
JP2012107063A5 (https=)
JP2006516571A5 (https=)
Elias et al. L-arginine as an adjuvant drug in the treatment of sickle cell anaemia.
SE0950390L (sv) System och process för tillverkning av en lösning med suspenderade fasta ämnen och användningar därför
JP2009510165A5 (https=)
JP5718639B2 (ja) 電離放射線誘発の損傷から哺乳類細胞を保護する方法
JP5665899B2 (ja) 癌の処置のための粘液腫ウイルス変異体
WO2011022633A3 (en) Method of threating cancer
JP2023531930A5 (https=)